Reported 1 day ago
In a recent episode of Mad Money, Jim Cramer expressed both caution and admiration for McKesson Corporation (MCK), noting its strong financial performance even amidst broader concerns in the drug distribution sector. Despite a significant top-line miss, McKesson reported an earnings beat and offered a higher-than-expected full-year forecast. Cramer emphasized risks related to regulatory pressures impacting the profitability of drug distributors, leading him to recommend caution in the industry while highlighting the potential of alternative investment opportunities.
Source: YAHOO